Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Bafna Pharmaceuticals Ltd. Share Price
Day's Range
Day's Range
Low
₹131.10
High
₹135.50
Price Summary
| Previous Close | ₹131.90 |
|---|---|
| Day's Range | ₹131.10 - ₹135.50 |
| Open | ₹135.50 |
| 52 Week Range | ₹72.01 - ₹202.06 |
| Volume | 926 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 1.23 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -10.45 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 0.00 |
| PAT Margin (%) | -4.43 |
| Face Value (₹) | 10.00 |
| ROCE(%) | -2.99 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 331.88 | 1524.66 |
| Expenses | N/A | N/A |
| PBT | 9.47 | 73.48 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 9.48 | 73.48 |
About Bafna Pharmaceuticals Ltd.
| Founded | 1995 |
|---|---|
| NSE Symbol | BAFNAPH |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,32,096.23 | 1,800.90 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,76,807.38 | 6,660.20 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,48,718.00 | 4,431.15 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,17,586.37 | 8,201.45 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,12,970.91 | 1,398.50 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,08,751.63 | 1,302.95 | 1,148.40 - 1,148.40 |
| Zydus Lifesciences Ltd. | 1,08,441.84 | 1,077.70 | 835.50 - 835.50 |
| Lupin Ltd. | 1,03,900.02 | 2,272.45 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 98,179.49 | 2,411.50 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 93,845.03 | 964.25 | 903.00 - 903.00 |
No Records Found
Latest News
Asarfi Hospital informs about conference call
Concord Biotech informs about press release
Coral Laboratories informs about secretarial compliance report
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Coral Laboratories has informed that it enclosed the Annual Secretarial Compliance Report dated May 30, 2026, of the Company for the financial year ended on March 31, 2026, issued by SARK & Associates LLP, Company Secretaries.
The above information is a part of company’s filings submitted to BSE.
Anlon Healthcare informs about press release
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulation) Anlon Healthcare has submitted the Press release of Audited Financial Results (Standalone and Consolidated) for the Quarter & Year Ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Unick Fix-a-form & Printers informs about annual secretarial compliance report
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Bafna Pharmaceuticals Ltd. is ₹131.90 as of 2026-05-29.
The market capitalisation of Bafna Pharmaceuticals Ltd. is ₹316.99 as of 2026-05-29.
The 1-year return of Bafna Pharmaceuticals Ltd. is 0.00% as of 2026-05-29.
The P/E ratio of Bafna Pharmaceuticals Ltd. is 42.73 as of 2026-05-31.
The 52-week high and low of Bafna Pharmaceuticals Ltd. are ₹202.06 and ₹72.01, respectively, as of 2026-05-29.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
